Label: VERMASODE- abrotanum, artemisia vulgaris, cina, juglans nigra, spigelia anthelmia, teucrium marum, sabadilla, silicea, tanacetum vulgare, graphites, influenzinum, morbillinum, diphtherinum, mononucleosis virus nosode, epstein-barr virus nosode, herpes zoster nosode, poliomyelitis nosode, haemophilus, hepatitis a nosode, hepatitis c nosode, pneumococcinum, coxsackie a2, a7, b1, b3, b4 nosode liquid
-
Contains inactivated NDC Code(s)
NDC Code(s): 43772-0025-1 - Packager: Synergy Formulas, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved homeopathic
DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
Drug Label Information
Updated January 16, 2015
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
ACTIVE INGREDIENTS:
Abrotanum, Artemisia Vulgaris, Cina, Juglans Nigra, Spigelia Anthelmia, Teucrium Marum 3X, Sabadilla 3X, 6X, Silicea, Tanacetum Vulgare 12X, Graphites 12X, 30X, 60X, Influenzinum 30X, 60X, 200X, 1000X, Morbillinum, Diphtherinum, Mononucleosis Virus Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode, Poliomyelitis Nosode, Haemophilus, Hepatitis A Nosode, Hepatitis C Nosode, Pneumococcinum 30X, 60X, 200X, 1000X, Coxsackie A2, A7, B1, B3, B4 Nosode 200C.
- INDICATIONS:
- WARNINGS:
- KEEP OUT OF REACH OF CHILDREN:
- DIRECTIONS:
- INDICATIONS:
- INACTIVE INGREDIENTS:
- QUESTIONS:
- PACKAGE LABEL DISPLAY:
-
INGREDIENTS AND APPEARANCE
VERMASODE
abrotanum, artemisia vulgaris, cina, juglans nigra, spigelia anthelmia, teucrium marum, sabadilla, silicea, tanacetum vulgare, graphites, influenzinum, morbillinum, diphtherinum, mononucleosis virus nosode, epstein-barr virus nosode, herpes zoster nosode, poliomyelitis nosode, haemophilus, hepatitis a nosode, hepatitis c nosode, pneumococcinum, coxsackie a2, a7, b1, b3, b4 nosode liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43772-0025 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ARTEMISIA ABROTANUM FLOWERING TOP (UNII: QG07G580U0) (ARTEMISIA ABROTANUM FLOWERING TOP - UNII:QG07G580U0) ARTEMISIA ABROTANUM FLOWERING TOP 3 [hp_X] in 1 mL ARTEMISIA VULGARIS ROOT (UNII: 32MP823R8S) (ARTEMISIA VULGARIS ROOT - UNII:32MP823R8S) ARTEMISIA VULGARIS ROOT 3 [hp_X] in 1 mL ARTEMISIA CINA PRE-FLOWERING TOP (UNII: 28M1820ACT) (ARTEMISIA CINA FLOWER - UNII:28M1820ACT) ARTEMISIA CINA PRE-FLOWERING TOP 3 [hp_X] in 1 mL BLACK WALNUT (UNII: 02WM57RXZJ) (BLACK WALNUT - UNII:02WM57RXZJ) BLACK WALNUT 3 [hp_X] in 1 mL SPIGELIA ANTHELMIA (UNII: WYT05213GE) (SPIGELIA ANTHELMIA - UNII:WYT05213GE) SPIGELIA ANTHELMIA 3 [hp_X] in 1 mL TEUCRIUM MARUM (UNII: 10464S0TAA) (TEUCRIUM MARUM - UNII:10464S0TAA) TEUCRIUM MARUM 3 [hp_X] in 1 mL SCHOENOCAULON OFFICINALE SEED (UNII: 6NAF1689IO) (SCHOENOCAULON OFFICINALE SEED - UNII:6NAF1689IO) SCHOENOCAULON OFFICINALE SEED 3 [hp_X] in 1 mL SILICON DIOXIDE (UNII: ETJ7Z6XBU4) (COLLOIDAL SILICON DIOXIDE - UNII:ETJ7Z6XBU4) SILICON DIOXIDE 12 [hp_X] in 1 mL TANACETUM VULGARE TOP (UNII: D52957JQ8M) (TANACETUM VULGARE TOP - UNII:D52957JQ8M) TANACETUM VULGARE TOP 12 [hp_X] in 1 mL GRAPHITE (UNII: 4QQN74LH4O) (GRAPHITE - UNII:4QQN74LH4O) GRAPHITE 12 [hp_X] in 1 mL INFLUENZA A VIRUS (UNII: R9HH0NDE2E) (INFLUENZA A VIRUS - UNII:R9HH0NDE2E) INFLUENZA A VIRUS 30 [hp_X] in 1 mL INFLUENZA B VIRUS (UNII: 1314JZ2X6W) (INFLUENZA B VIRUS - UNII:1314JZ2X6W) INFLUENZA B VIRUS 30 [hp_X] in 1 mL MEASLES VIRUS (UNII: HT3R7C012Q) (MEASLES VIRUS - UNII:HT3R7C012Q) MEASLES VIRUS 30 [hp_X] in 1 mL DIPHTHERIAL RESPIRATORY PSEUDOMEMBRANE HUMAN (UNII: 50SG618FGN) (DIPHTHERIAL RESPIRATORY PSEUDOMEMBRANE HUMAN - UNII:50SG618FGN) DIPHTHERIAL RESPIRATORY PSEUDOMEMBRANE HUMAN 30 [hp_X] in 1 mL HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) HUMAN HERPESVIRUS 4 30 [hp_X] in 1 mL HUMAN HERPESVIRUS 3 (UNII: 9885M7D6JP) (HUMAN HERPESVIRUS 3 - UNII:9885M7D6JP) HUMAN HERPESVIRUS 3 30 [hp_X] in 1 mL POLIOVIRUS (UNII: FZJ641678T) (POLIOVIRUS - UNII:FZJ641678T) POLIOVIRUS 30 [hp_X] in 1 mL HAEMOPHILUS INFLUENZAE TYPE B (UNII: F2TW0N64FI) (HAEMOPHILUS INFLUENZAE TYPE B - UNII:F2TW0N64FI) HAEMOPHILUS INFLUENZAE TYPE B 30 [hp_X] in 1 mL HEPATITIS A VIRUS (UNII: G54MT8V18G) (HEPATITIS A VIRUS - UNII:G54MT8V18G) HEPATITIS A VIRUS 30 [hp_X] in 1 mL HEPATITIS C VIRUS (UNII: QI56415283) (HEPATITIS C VIRUS - UNII:QI56415283) HEPATITIS C VIRUS 30 [hp_X] in 1 mL STREPTOCOCCUS PNEUMONIAE (UNII: BT6U234YR2) (STREPTOCOCCUS PNEUMONIAE - UNII:BT6U234YR2) STREPTOCOCCUS PNEUMONIAE 30 [hp_X] in 1 mL HUMAN COXSACKIEVIRUS A2 (UNII: 82KK5J435E) (HUMAN COXSACKIEVIRUS A2 - UNII:82KK5J435E) HUMAN COXSACKIEVIRUS A2 200 [hp_C] in 1 mL HUMAN COXSACKIEVIRUS A7 (UNII: P3026TK92O) (HUMAN COXSACKIEVIRUS A7 - UNII:P3026TK92O) HUMAN COXSACKIEVIRUS A7 200 [hp_C] in 1 mL HUMAN COXSACKIEVIRUS B1 (UNII: ADL68M27WD) (HUMAN COXSACKIEVIRUS B1 - UNII:ADL68M27WD) HUMAN COXSACKIEVIRUS B1 200 [hp_C] in 1 mL HUMAN COXSACKIEVIRUS B3 (UNII: 69O1DAO10G) (HUMAN COXSACKIEVIRUS B3 - UNII:69O1DAO10G) HUMAN COXSACKIEVIRUS B3 200 [hp_C] in 1 mL HUMAN COXSACKIEVIRUS B4 (UNII: FYF75V7FDY) (HUMAN COXSACKIEVIRUS B4 - UNII:FYF75V7FDY) HUMAN COXSACKIEVIRUS B4 200 [hp_C] in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) ALCOHOL (UNII: 3K9958V90M) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43772-0025-1 60 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved homeopathic 01/16/2015 Labeler - Synergy Formulas, Inc. (069579220) Registrant - Apotheca Company (844330915) Establishment Name Address ID/FEI Business Operations Apotheca Company 844330915 manufacture(43772-0025) , api manufacture(43772-0025) , label(43772-0025) , pack(43772-0025)
